Evidence map›Paper›PMID 33615171›Full record

ArticleACS pharmacology & translational science2021

Spontaneous

Lucy I Darakjian, Aimilia Rigakou, Andrew Brannen, Mohammed H Qusa, Niki Tasiakou, Panagiotis Diamantakos, Miranda N Reed, Peter Panizzi, Melissa D Boersma, Eleni Melliou and 3 more

Open access · greenAbstract read
In one paragraph

Article in ACS pharmacology & translational science, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.0field-weighted citation impact, top 29% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 15 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Influence of Olive Oil Components on Ion Channels.Molecules (Basel, Switzerland) · 2025
    Review
  5. Review
  6. Article
  7. Article
  8. Nutrients · 2023
    Article
  9. Article
  10. Article
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 3 institutions in 2 countries.

Lucy I DarakjianDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University. Auburn, Alabama 36849, United States.
Aimilia RigakouDepartment of Pharmacy, Laboratory of Pharmacognosy and Natural Products Chemistry, National and Kapodistrian University of Athens, Athens, 157 71, Greece.
Andrew BrannenDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University. Auburn, Alabama 36849, United States.
Mohammed H QusaSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, Louisiana 71201, United States.
Niki TasiakouDepartment of Pharmacy, Laboratory of Pharmacognosy and Natural Products Chemistry, National and Kapodistrian University of Athens, Athens, 157 71, Greece.
Panagiotis DiamantakosDepartment of Pharmacy, Laboratory of Pharmacognosy and Natural Products Chemistry, National and Kapodistrian University of Athens, Athens, 157 71, Greece.
Miranda N ReedDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University. Auburn, Alabama 36849, United States.
Peter PanizziDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University. Auburn, Alabama 36849, United States.
Melissa D BoersmaDepartment of Chemistry and Biochemistry, Auburn University, Auburn, Alabama 36849, United States.
Eleni MelliouDepartment of Pharmacy, Laboratory of Pharmacognosy and Natural Products Chemistry, National and Kapodistrian University of Athens, Athens, 157 71, Greece.
Khalid A El SayedSchool of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, Louisiana 71201, United States.
Prokopios MagiatisDepartment of Pharmacy, Laboratory of Pharmacognosy and Natural Products Chemistry, National and Kapodistrian University of Athens, Athens, 157 71, Greece.
Amal KaddoumiDepartment of Drug Discovery and Development, Harrison School of Pharmacy, Auburn University. Auburn, Alabama 36849, United States.
Auburn University · USNational and Kapodistrian University of Athens · GRUniversity of Louisiana at Monroe · US

Funding

Olive-derived oleocanthal as a novel natural product molecule to restore cerebrovascular function and integrity in a CAA mouse modelR21NS101506 · NINDS · AUBURN UNIVERSITY AT AUBURN · PI KHALIL KADDOUMI, AMAL F, PANIZZI, PETER ROLF · 2017 to 2018
$401k
NINDS NIH HHS R21 NS101506
6 · The paper itself

Abstract

Since the first discovery of its ibuprofen-like anti-inflammatory activity in 2005, the olive phenolic (-)-oleocanthal gained great scientific interest and popularity due to its reported health benefits. (-)-Oleocanthal is a monophenolic secoiridoid exclusively occurring in extra-virgin olive oil (EVOO). While several groups have investigated oleocanthal pharmacokinetics (PK) and disposition, none was able to detect oleocanthal in biological fluids or identify its PK profile that is essential for translational research studies. Besides, oleocanthal could not be detected following its addition to any fluid containing amino acids or proteins such as plasma or culture media, which could be attributed to its unique structure with two highly reactive aldehyde groups. Here, we demonstrate that oleocanthal spontaneously reacts with amino acids, with high preferential reactivity to glycine compared to other amino acids or proteins, affording two products: an unusual glycine derivative with a tetrahydropyridinium skeleton that is named oleoglycine, and our collective data supported the plausible formation of tyrosol acetate as the second product. Extensive studies were performed to validate and confirm oleocanthal reactivity, which were followed by PK disposition studies in mice, as well as cell culture transport studies to determine the ability of the formed derivatives to cross physiological barriers such as the blood-brain barrier. To the best of our knowledge, we are showing for the first time that (-)-oleocanthal is biochemically transformed to novel products in amino acids/glycine-containing fluids, which were successfully monitored

Identifiers

PMID33615171
PMCPMC7887843
OpenAlexW3118556989

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.